加拿大疫苗伤害支持计划的前进方向是什么?
Sam Halabi1,2, Kumanan Wilson3,4,5,6
1O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington D.C., USA.
Canadian journal of public health = Revue canadienne de sante publique
|February 20, 2026
概括
加拿大加拿大加拿大加拿大加拿大加拿大
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 免疫接种计划 免疫接种计划
背景情况:
- 加拿大疫苗伤害赔偿计划于2021年6月启动.
- 它是最后一个G7国家实施这样的系统.
- 疫苗损伤赔偿的全球先例已经存在.
研究的目的:
- 审查加拿大疫苗伤害赔偿计划的发展情况.
- 分析项目所遇到的挑战.
- 为计划改进提供建议.
主要方法:
- 政策分析. 政策分析.
- 审查计划实施情况.
- 对国际补偿模式的文献综述.
主要成果:
- 与国际同行相比,加拿大计划在建立方面遇到了延迟.
- 该计划最近遭遇了严格审查.
- 该计划的初始阶段正在结束.
结论:
- 提供了建议,以确保该计划实现其目标.
- 应对挑战对于计划的成功至关重要.
- 该计划的演变需要持续评估.
更多相关视频
11:18An Ex Vivo Laser-induced Spinal Cord Injury Model to Assess Mechanisms of Axonal Degeneration in Real-time
Published on: November 25, 2014
11.5K
11:57Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
9.7K
相关概念视频
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Vaccinations
52.1K
Overview
52.1K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
25
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
25
